- Home
- NKTX vs MERC Comparison
NKTX vs MERC Comparison
Compare NKTX & MERC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NKTX | MERC |
|---|---|---|
| Founded | 2015 | 1968 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Paper |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 132.8M | 106.5M |
| IPO Year | 2020 | 2005 |
Fundamental Metrics
Financial Performance| Metric | NKTX | MERC |
|---|---|---|
| Price | $2.32 | $1.62 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $13.25 | $2.50 |
| AVG Volume (30 Days) | ★ 669.7K | 604.4K |
| Earning Date | 01-01-0001 | 05-13-2026 |
| Dividend Yield | N/A | ★ 9.15% |
| EPS Growth | ★ 33.33 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,169,145,000.00 |
| Revenue This Year | N/A | $13.75 |
| Revenue Next Year | N/A | $10.12 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 25.50 |
| 52 Week Low | $1.31 | $1.48 |
| 52 Week High | $2.81 | $6.78 |
Technical Indicators
Market Signals| Indicator | NKTX | MERC |
|---|---|---|
| Relative Strength Index (RSI) | 46.74 | 34.97 |
| Support Level | $1.95 | $1.54 |
| Resistance Level | $2.47 | $2.30 |
| Average True Range (ATR) | 0.19 | 0.09 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 4.76 | 3.41 |
Price Performance
Historical ComparisonAbout NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About MERC Mercer International Inc.
Mercer International Inc is a forest products company with two reportable operating segments in pulp and solid wood. The pulp segment consists of the manufacture, sale, and distribution of pulp, electricity, and chemicals. The company has a geographical presence in the USA, Germany, China, and Other countries, where the majority of revenue is generated from the USA. The majority of the revenue is generated from the Pulp segment.